Quest Diagnostics director granted 144 phantom units
Quest Diagnostics director Timothy C. Wentworth reported a routine compensation-related transaction involving deferred equity-based awards.
Rhea-AI Filing Summary
Quest Diagnostics director Timothy C. Wentworth reported a routine compensation-related transaction involving deferred equity-based awards. He received 144 Phantom Stock Units, representing an elective deferral of his director cash compensation under the company’s Amended and Restated Deferred Compensation Plan for Directors. Each unit is tied to Quest Diagnostics common stock and is payable in cash when his service as a director ends. Following this grant, he holds 342 Phantom Stock Units in total. This filing reflects a non-cash grant/award acquisition rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
WENTWORTH TIMOTHY C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 144 | $0.00 | $0.00 |
Holdings After Transaction:
Phantom Stock Units — 342 shares (Direct)
Footnotes (1)
- F1. Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
Key Figures
Phantom Stock Units granted: 144 units
Phantom Stock Units after transaction: 342 units
Transaction price per unit: $0.0000
+1 more
4 metrics
Phantom Stock Units granted
144 units
Grant/award acquisition on 2026-07-01
Phantom Stock Units after transaction
342 units
Total units beneficially owned following grant
Transaction price per unit
$0.0000
Grant price for Phantom Stock Units
Underlying common stock equivalent
144 shares
Underlying Quest Diagnostics common stock for the new units
Key Terms
Phantom Stock Units, elective deferrals, Deferred Compensation Plan for Directors, derivative, +1 more
5 terms
Phantom Stock Units financial
"Phantom stock units resulting from elective deferrals of a director's cash compensation"
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
elective deferrals financial
"Phantom stock units resulting from elective deferrals of a director's cash compensation"
Deferred Compensation Plan for Directors financial
"pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors"
A deferred compensation plan for directors is an arrangement that lets board members postpone receiving part of their pay until a later date—often retirement or a set future time—so the money can grow or be paid under specified conditions. Think of it like directing a portion of your paycheck into a locked savings account that pays out later; investors care because it creates future cash or stock obligations, signals how the company motivates and retains leadership, and can affect shareholder value through timing of payouts or potential dilution.
derivative financial
"transaction_type": "derivative""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What did Quest Diagnostics (DGX) director Timothy C. Wentworth report on this Form 4?
Timothy C. Wentworth reported receiving 144 Phantom Stock Units as a grant under Quest Diagnostics’ deferred compensation plan for directors. These units represent deferred director fees and are linked to the value of Quest Diagnostics common stock, but are ultimately payable in cash.
How many Phantom Stock Units does Timothy C. Wentworth hold after this DGX transaction?
After this transaction, Timothy C. Wentworth holds a total of 342 Phantom Stock Units. The filing shows a grant of 144 new units, bringing his post-transaction balance to 342, all recorded as directly owned derivative securities linked to Quest Diagnostics common stock.
Is Timothy C. Wentworth buying or selling Quest Diagnostics (DGX) stock in this Form 4?
This Form 4 does not show open-market buying or selling of Quest Diagnostics shares. Instead, it reports a grant of 144 Phantom Stock Units as deferred director compensation, which are derivative units payable in cash rather than a direct purchase or sale of common stock.
What are Phantom Stock Units in the Quest Diagnostics director deferred compensation plan?
Phantom Stock Units are bookkeeping units tied to Quest Diagnostics common stock value, used in the director deferred compensation plan. According to the filing, these units result from elective deferrals of a director’s cash compensation and become payable in cash when the director’s service ends.
When will Timothy C. Wentworth receive cash from these Quest Diagnostics Phantom Stock Units?
The filing states that Phantom Stock Units become payable in cash upon Timothy C. Wentworth’s termination of service as a director. Until then, they remain deferred compensation entries linked to the value of Quest Diagnostics common stock, not currently paid out or settled.
AI-generated analysis. How Rhea-AI works. Not financial advice.
